savolitinib

Showing 1 posts of 1 posts found.

shutterstock_159488225

AstraZeneca lung cancer drug proves able to shrink EGFR mutation-positive tumours

October 17, 2017
Manufacturing and Production, Research and Development AstraZeneca, Cancer, Chi-Med, lung cancer, pharma, savolitinib

AstraZeneca and its partner Hutchison China MedTech, also known as Chi-Med, have announced positive data for savolitinib in combination with …

Latest content